FDA Inspection
ADMA Biologics, IncADMA Biologics, Inc – FDA Inspection, Apr 12, 2018
Record Details
This FDA Inspection record concerns ADMA Biologics, Inc, with an inspection on April 12, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · b5405d37-cfbd-4a12-aea8-1f51ffeecff0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1049629
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of ADMA Biologics, Inc
7| Date | Classification | Office | Project area |
|---|---|---|---|
| December 11, 2024 | VAI | Florida District Office | Blood and Blood Products |
| September 20, 2023 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
| August 12, 2021 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| March 3, 2016 | OAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 14, 2014 | OAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for ADMA Biologics, Inc
- FDA Inspection 1256275 - 2024-12-11
- FDA Inspection 1219342 - 2023-09-20
- FDA Inspection 1150114 - 2021-08-12
- FDA Inspection 974061 - 2016-03-03
- FDA Inspection 892829 - 2014-08-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.